AAAAAA

   
Results: 1-8 |
Results: 8
5-HT6 serotonin receptor binding affinities of N-1-benzenesulfonyl and related tryptamines
Authors: Lee, M Rangisetty, JB Dukat, M Slassi, A Maclean, N Lee, DKH Glennon, RA
Citation: M. Lee et al., 5-HT6 serotonin receptor binding affinities of N-1-benzenesulfonyl and related tryptamines, MED CHEM RE, 10(4), 2000, pp. 230-242
5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: Potential treatments for migraine
Authors: Meng, CQ Rakhit, S Lee, DKH Kambo, R McCallum, KL Mazzocco, L Dyne, K Slassi, A
Citation: Cq. Meng et al., 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: Potential treatments for migraine, BIOORG MED, 10(9), 2000, pp. 903-905
Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: Potential therapeutic applications for epilepsy and obesity
Authors: Isaac, M Slassi, A O'Brien, A Edwards, L MacLean, N Bueschkens, D Lee, DKH McCallum, K De Lannoy, I Demchyshyn, L Kamboj, R
Citation: M. Isaac et al., Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: Potential therapeutic applications for epilepsy and obesity, BIOORG MED, 10(9), 2000, pp. 919-921
5-alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists
Authors: Slassi, A Edwards, L O'Brien, A Meng, CQ Xin, T Seto, C Lee, DKH MacLean, N Hynd, D Chen, C Wang, H Kamboj, R Rakhit, S
Citation: A. Slassi et al., 5-alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists, BIOORG MED, 10(15), 2000, pp. 1707-1709
2-Substituted tryptamines: Agents with selectivity for 5-HT6 serotonin receptors
Authors: Glennon, RA Lee, M Rangisetty, JB Dukat, M Roth, BL Savage, JE McBride, A Rauser, L Hufeisen, S Lee, DKH
Citation: Ra. Glennon et al., 2-Substituted tryptamines: Agents with selectivity for 5-HT6 serotonin receptors, J MED CHEM, 43(5), 2000, pp. 1011-1018
Development of an in vitro screening assay for compounds that increase bone formation
Authors: Hahn, SE Yu, M Tong, S Geisterfer-Lowrance, AAT Sindrey, D Lee, DKH
Citation: Se. Hahn et al., Development of an in vitro screening assay for compounds that increase bone formation, J BIOMOL SC, 4(6), 1999, pp. 363-371
Conformationally constrained 5-(thienyl)tryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: Potential treatments for migraine
Authors: Slassi, A Meng, CQ Dyne, K Wang, X Lee, DKH Kamboj, R McCallum, KL Mazzacco, L Rakhit, S
Citation: A. Slassi et al., Conformationally constrained 5-(thienyl)tryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: Potential treatments for migraine, MED CHEM RE, 9(9), 1999, pp. 668-674
Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat
Authors: Owolabi, JB Rizkalla, G Tehim, A Ross, GM Riopelle, RJ Kamboj, R Ossipov, M Bian, D Wegert, S Porreca, F Lee, DKH
Citation: Jb. Owolabi et al., Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat, J PHARM EXP, 289(3), 1999, pp. 1271-1276
Risultati: 1-8 |